Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Vous n'êtes pas connecté
Researchers from the University of Missouri School of Medicine, USA, found that a targeted gene therapy may make acute myeloid leukaemia (AML) more sensitive to chemotherapy, while also protecting the heart against toxicity often caused by cancer treatments. Acute myeloid leukaemia is the most common type of leukaemia in adults and the resulting chemotherapy treatment [...]
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Acute myeloid leukaemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...
Servier India, a subsidiary of the leading French pharmaceutical Servier Group, recently announced the launch of Ivosidenib (Tibsovo), an oral...
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute, USA, report the identification of a novel combination therapy...
Researchers at UC San Diego School of Medicine have developed a gene therapy for Alzheimer's that may protect the brain and preserve cognitive...
Researchers at UC San Diego School of Medicine have developed a gene therapy for Alzheimer's that may protect the brain and preserve cognitive...
Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment...
Acute Myeloid Leukemia (AML) grows at lightning speed and demands urgent, personalised treatment, here’s why early diagnosis is critical.